GlassScriptPhysician profile
David A Guthman
NPI 1073585436
$3,934.34
in general payments reported to CMS, 2019-2025
52 companies · $463 in 2025
The $463 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $214 · 2021: $1,151 · 2022: $234 · 2023: $586 · 2024: $580 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.54 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,013.94 | 2021-2025 | Urolift, Barrigel |
| Antares Pharma, INC. | $342.51 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Csl Behring | $170.76 | 2019-2024 | Kcentra |
| Boston Scientific Corporation | $133.30 | 2021-2024 | Rezum Generator |
| Astellas Pharma US INC | $129.69 | 2019-2022 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.96 | 2022-2024 | Gattex |
| Pfizer INC. | $113.94 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $105.55 | 2019-2025 | Keytruda, Lynparza |
| Sumitomo Pharma America, INC. | $104.07 | 2025 | Gemtesa |
| Allergan, INC. | $97.98 | 2019-2021 | |
| Kerecis Limited | $95.62 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Procept Biorobotics Corporation | $95.51 | 2021-2024 | Aquabeam System |
| Laborie Medical Technologies Corp. | $94.25 | 2021-2025 | |
| Olympus America INC. | $92.11 | 2019-2025 | Olympus, Itind System, Uretero-Reno Fiberscope |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Guthman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.